Literature DB >> 2535996

Clonal origin of recurrent hepatocellular carcinomas.

P J Chen1, D S Chen, M Y Lai, M H Chang, G T Huang, P M Yang, J C Sheu, S C Lee, H C Hsu, J L Sung.   

Abstract

Recurrence of hepatocellular carcinoma after treatment is frequent. To study the clonal origin of the recurrent tumors, we examined five pairs of hepatocellular carcinomas resected from individual hepatitis B surface antigen carriers. Using integrated hepatitis B virus DNA as a marker, tumor clonality was determined by Southern blot analysis. In 2 cases the second tumor contained the same integrated viral DNA as the first one. In the other 3 cases, the clonality of the second cancer differed. We conclude that recurrent hepatocellular carcinomas originate from the first tumor in some cases but represent de novo neoplasms in others.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535996     DOI: 10.1016/0016-5085(89)91581-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Effect of liver regeneration on malignant hepatic tumors.

Authors:  Ji-Hua Shi; Pål-Dag Line
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Massimo Del Gaudio; Andrea Gardini; Matteo Cescon; Giovanni Varotti; Francesco Cetta; Antonino Cavallari
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

4.  Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?

Authors:  Chung-Bao Hsieh; Teng-Wei Chen; Chi-Ming Chu; Heng-Cheng Chu; Cheng-Ping Yu; Kuo-Piao Chung
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

Review 5.  Therapeutic modalities and prognostic factors for primary and secondary liver tumors.

Authors:  T Lehnert; G Otto; C Herfarth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 6.  Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.

Authors:  Tianfu Wen; Chen Jin; Antonio Facciorusso; Matteo Donadon; Ho-Seong Han; Yilei Mao; Chaoliu Dai; Shuqun Cheng; Bixiang Zhang; Baogang Peng; Shunda Du; Changjun Jia; Feng Xu; Jie Shi; Juxian Sun; Peng Zhu; Satoshi Nara; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

7.  Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.

Authors:  Shenghua Hao; Ping Fan; Shaofei Chen; Caixue Tu; Chidan Wan
Journal:  J Gastrointest Surg       Date:  2016-11-04       Impact factor: 3.452

8.  Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.

Authors:  Fuminori Sonohara; Yoshikuni Inokawa; Mitsuhiro Hishida; Mitsuro Kanda; Yoko Nishikawa; Suguru Yamada; Tsutomu Fujii; Hiroyuki Sugimoto; Yasuhiro Kodera; Shuji Nomoto
Journal:  Oncol Lett       Date:  2016-10-11       Impact factor: 2.967

9.  Different DNA changes in primary and recurrent hepatocellular carcinoma.

Authors:  S F Ding; R P Jalleh; C B Wood; L Bowles; J D Delhanty; J Dooley; N A Habib
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

10.  An evaluation of the flow cytometric nuclear DNA analysis of intrahepatic multinodular hepatocellular carcinoma for a diagnosis of their multicentricity.

Authors:  M Matsuda; M Yamamoto; Y Matsumoto
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.